5. Calcification; 90 % on CT scan
T2 - weighted well circumscribed, homogeneously
hyper-intense
T1 weighted, contrast enhanced, heterogenously hypo-
intense with no significant enhancement
70 % calcified; hypo intense on T1 and T2, but micro
calcification can demonstrate hyperintense on T1
weighted
Radiological Presentation
6.
7. 73% micro-calcification; 16 % cystic; 33- 41 % have
component of ependymal or neoplastic astrocytoma
Penetrate intact parenchyma
Fried egg appearance
Chicken wire vascular pattern
Round monotonous nuclei surrounding eccentric rim
of eosinophilic cytoplasm with lacked cell process
GFAP staining; mostly for astrocyte component
Pathology
8.
9. WHO class II (low grade)
WHO class III (High Grade)
Smith grading System; compose of five variables
o N/c ratio
o Maximal cell density
o Pleomorphism; related to Survival
o Endothelial proliferation
o Necrosis
Grading System
10.
11. 1p or 19 q or both allelic loss responses on
chemotherapy
PVC; Procarbazine 60 mg/m2 IV, CCNU aka lomustine
110 mg/ m2 PO, Vincristine 1.4 mg/m2 all given on 29
days cycle repeated every 6 weeks.
Chemotherapy
12. Indication of surgery
Significant mass effect regardless of grade
Without mass effect;
low grade: gross total resection; improve survival
High grade: no improvement in survival, either with
gross total or partial de bulking or biopsy
Pink to red friable mass, can have false plane of
demarcation between tumor and normal brain
parenchyma
Surgery
13. Controversial
Survival is better with > 45 Gy
No improvement in 5 year survival with or with out
XRT
Post operative Radiation
14. Pure ODG have better outcome from astrocyte
component
Median survival; grade A; 94 months, grade B; 51
months, grade C; 45 months and grade D; 17 months
10 year survival; surgically treated mean 52 months
Calcified; 108 months vs Non- calcified 58 month
Frontal lobe; 37 months vs temporal lobe; 28 months
Chromosome 1 p loss have longer survival
Prognosis